Pharma news
Refine search
Americas
The US Supreme Court was split yesterday (October 15) after hearing arguments in a high-profile case that will determine whether generic drug companies are free to market a cheaper version of Teva’s blockbuster multiple sclerosis drug. 16 October 2014
Pharma
UK-based law firm Carpmaels & Ransford LLP has continued to expand its IP group with the appointment of a life sciences litigator to its London office. 15 October 2014
Americas
The highest court in the US will hear a dispute today (October 15) between pharmaceutical company Teva and generic rivals that are looking to market versions of its multiple sclerosis drug Copaxone (glatiramer acetate). 15 October 2014
Americas
The US government has launched a new investigation into India’s IP regime just weeks after a meeting between the country’s new prime minister and US President Barack Obama. 14 October 2014
Asia
US pharmaceutical company Pfizer has been granted a patent for an anti-fungal drug in India after overcoming local opposition. 13 October 2014
Americas
US biopharmaceutical company Sucampo has resolved patent litigation related to, and agreed a licensing deal for, its Amitiza (lubiprostone) capsules, used to treat constipation. 10 October 2014
Asia-Pacific
Criminal gangs in Australia are branching away from traditional forms of counterfeiting and are targeting pharmaceuticals, an Australian customs official has revealed. 9 October 2014
Pharma
Drug business Teva invalidated two patents held by Leo Pharma today and will seek to launch a generic version of one of the company’s skin condition treatments. 6 October 2014
Pharma
Pharmaceutical company CleveXel Pharma has agreed a deal with a technology transfer company to licence two patents related to the treatment of bone marrow cancer. 6 October 2014
Americas
Healthcare advocate Médecins Sans Frontières has urged Indian Prime Minister Narendra Modi not to change IP laws which allow for the production of generic medicines. 30 September 2014